查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589095

消费者保健市场：依产品、分布 - 2025-2030 年全球预测

Consumer Healthcare Market by Product (Dietary Supplements, OTC Pharmaceuticals), Distribution (Departmental Stores, Independent Retailers, Pharmacies or Drugstores) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年消费者医疗保健市场规模为3,330.3亿美元，预估2024年将达3,569.4亿美元，复合年增长率为7.38%，2030年将达5,483.1亿美元。

消费者医疗保健是医疗保健产业中一个快速发展的领域，包括健康产品、成药、营养食品和消费者为自我护理而购买的个人护理用品。健康意识的提高、慢性病盛行率的上升、人口老化以及减轻传统医疗保健服务负担的自我自我治疗趋势推动了消费者医疗保健的需求。消费保健品应用广泛，包括预防保健、疾病管理、营养食品和个人保健等，最终用途是寻求便捷健康解决方案的个人家庭和零售消费者。关键的成长要素包括产品配方的技术进步、消费者数位健康素养的提高以及向整体健康和保健方法的转变。利用数位平台的直接面向消费者和个人化健康解决方案存在机会。透过与电子商务巨头的策略联盟以及投资资料分析以增强消费者洞察力，还有扩大市场覆盖范围的潜力。然而，挑战包括监管障碍、价格敏感性以及来自学名药药和自有品牌药物的激烈竞争，这些可能会阻碍成长。公司还需要意识到线上健康领域可能产生的错误讯息，这会影响消费者的信任。个人化营养、远端医疗和人工智慧健康监测等领域的创新可以提供竞争优势。随着消费者日益要求环保责任，您还可以探索永续和环保的产品线。市场动态是动态的并且以消费者为中心，并且越来越重视便利性和可及性。保持敏捷性并响应不断变化的消费者偏好和技术趋势对于在这个快速成长的市场中实现持续成长和成功至关重要。该研究的建议包括投资于研发以保持领先于新的健康趋势，并努力提高产品资讯的透明度以建立消费者的信任。

主要市场统计
基准年[2023] 3330.3亿美元
预测年份 [2024] 3569.4亿美元
预测年份 [2030] 5483.1亿美元
复合年增长率（%） 7.38%

市场动态：揭示快速发展的消费者医疗保健市场的关键市场洞察

供需的动态交互作用正在改变消费者医疗保健市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 老年人口的增加和消费者对自我治疗产品的倾向
    • 政府支持改善获得负担得起的医疗保健的机会
    • 扩大自有品牌产品的采用消费者医疗保健
  • 市场限制因素
    • 缺乏活性成分的仿冒品的可用性
  • 市场机会
    • 提高健康和预防药物的核准率
    • 线上药局的快速成长和透过线上平台增加的可得性
  • 市场挑战
    • 对消费者保健产品滥用和误用的担忧

波特五力：驾驭消费者医疗保健市场的策略工具

波特的五力架构是了解消费者医疗保健市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解消费保健市场的外部影响

外部宏观环境因素在塑造消费者医疗保健市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解消费保健市场的竞争状况

对消费者医疗保健市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 消费者医疗保健市场定位矩阵供应商绩效评估

FPNV定位矩阵是评估消费者医疗保健市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製消费者保健市场的成功之路

对于希望加强在全球市场的影响力的公司来说，消费者医疗保健市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧和自我治疗产品的消费趋势
      • 政府支持提供负担得起的、改善的医疗保健服务
      • 自有品牌消费者保健产品的采用率增加
    • 抑制因素
      • 分销不含活性药物成分的仿冒品
    • 机会
      • 提高保健和预防药物的核准率
      • 线上药局的快速成长和透过线上平台增加的可用性
    • 任务
      • 对消费者保健产品滥用和误用的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章消费保健市场：依产品分类

  • 食品补充品
  • 非处方药

第七章消费保健市场经销商

  • 百货公司
  • 独立零售商
  • 药房或药局
  • 专业零售商
  • 超级市场或大卖场

第八章美洲消费保健市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区消费保健市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲消费保健市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • SPE Capital 收购突尼斯领先营养食品公司 Vital 的多数股权
    • Nutrilitius 透过推出新型营养食品扩大了其产品组合，释放了食品科学与技术的力量。
    • LBB Specialties 与帝斯曼宣布在北美食品补充剂分销领域建立合作伙伴关係
    • Cosmos Health 透过亚马逊和 eBay 在德国和奥地利推出 Sky Premium Life 营养食品
    • 保健补充品：塔塔消费者进入保健补充品领域并推出植物蛋白粉
    • Cipla Health 收购营养食品品牌“Endura Mass”
    • Orkla Health 收购 Healthspan
    • 安丽印度推出软糖和果冻条营养食品
    • Wellbeing Nutrition 融资 220 万美元，由 Fireside Ventures主导
    • 拜耳在印度设立消费者健康部门
  • 战略分析和建议

公司名单

  • Abbott Laboratories Inc.
  • Alembic Pharmaceuticals Ltd.
  • Alkem Laboratories Limited
  • AMCO Proteins
  • American Health Inc.
  • Amway Corporation by Alticor corporation
  • Axtria Inc.
  • BASF SE
  • Bayer AG
  • Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
  • Gemini Pharmaceuticals Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Henin Lukinz Pvt. Ltd.
  • Herbalife Ltd.
  • Hetero Drugs Ltd.
  • Himalaya Wellness Company
  • Iovate Health Sciences International Inc.
  • Ipsen SA
  • Johnson & Johnson Services, Inc.
  • Koninklijke DSM NV
  • Lonza Group Ltd.
  • Lupin Limited
  • Mankind Pharma
  • MusclePharm Corporation
  • Mylan Pharmaceuticals Pvt. Ltd. by Viatris
  • Nature's Bounty, Inc. by Nestle SA
  • Novartis AG
  • Omega Protein Corporation
  • Pfizer Inc.
  • Piramal Group
  • Procter & Gamble Company
  • PureTek Corporation
  • QuestNutrition
  • Reckitt Benckiser Group PLC
  • Sanofi SA
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Ventus Pharmaceuticals Private Limited
  • Zoic Biotech Private Limited
Product Code: MRR-433AB1DC291F

The Consumer Healthcare Market was valued at USD 333.03 billion in 2023, expected to reach USD 356.94 billion in 2024, and is projected to grow at a CAGR of 7.38%, to USD 548.31 billion by 2030.

Consumer healthcare is a rapidly evolving segment of the healthcare industry, encompassing wellness products, OTC drugs, dietary supplements, and personal care items that consumers purchase for self-care. The necessity for consumer healthcare is driven by the increasing health awareness, rising prevalence of chronic diseases, an aging population, and a trend towards self-medication which reduces the burden on traditional healthcare services. The application of consumer healthcare products spans across preventive care, disease management, nutritional supplementations, and personal wellness, with end-use in individual households and retail consumers seeking convenient health solutions. Key growth influencers include technological advancements in product formulations, increased digital health literacy among consumers, and a shift towards holistic health and wellness approaches. Opportunities exist in leveraging digital platforms for direct-to-consumer sales and personalized health solutions. Furthermore, there's potential in expanding market reach through strategic partnerships with e-commerce giants and investing in data analytics to enhance consumer insights. However, challenges include regulatory hurdles, price sensitivity, and intense competition from generic and private-label brands, which may hinder growth. Companies should also be wary of misinformation that can arise from online health spaces, affecting consumer trust. Innovating in areas such as personalized nutrition, telehealth, and AI-driven health monitoring can offer competitive advantages, as can exploring sustainable and eco-friendly product lines in response to growing consumer demand for environmental responsibility. The nature of the consumer healthcare market is dynamic and consumer-centric, with an increasing emphasis on convenience and accessibility. Staying agile and responsive to changing consumer preferences and technological trends will be critical for sustained growth and success in this burgeoning market. Recommendations include investing in research and development to stay ahead of emerging health trends and committing to transparency in product information to build consumer trust.

KEY MARKET STATISTICS
Base Year [2023] USD 333.03 billion
Estimated Year [2024] USD 356.94 billion
Forecast Year [2030] USD 548.31 billion
CAGR (%) 7.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Consumer Healthcare Market

The Consumer Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and inclination of consumers towards self-medication products
    • Government support to offer affordable and improved access to healthcare
    • Growing adoption of private labels consumer healthcare products
  • Market Restraints
    • Availability of counterfeit products that lack active pharmaceutical ingredients
  • Market Opportunities
    • Increasing approval rate of wellness and preventive medicines
    • Rapid growth of online pharmacies and improved availability through online platforms
  • Market Challenges
    • Concerns associated with abuse and misuse of consumer healthcare products

Porter's Five Forces: A Strategic Tool for Navigating the Consumer Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Consumer Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Consumer Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Consumer Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Consumer Healthcare Market

A detailed market share analysis in the Consumer Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Consumer Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Consumer Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Consumer Healthcare Market

A strategic analysis of the Consumer Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Consumer Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, AMCO Proteins, American Health Inc., Amway Corporation by Alticor corporation, Axtria Inc., BASF SE, Bayer AG, Bionova Lifesciences by Pragati Biocare Pvt. Ltd., Boehringer Ingelheim International GmbH, Cipla, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, Endo Pharmaceuticals PLC by DuPont de Nemours, Inc., Gemini Pharmaceuticals Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Henin Lukinz Pvt. Ltd., Herbalife Ltd., Hetero Drugs Ltd., Himalaya Wellness Company, Iovate Health Sciences International Inc., Ipsen S.A., Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Lonza Group Ltd., Lupin Limited, Mankind Pharma, MusclePharm Corporation, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Nature's Bounty, Inc. by Nestle S.A., Novartis AG, Omega Protein Corporation, Pfizer Inc., Piramal Group, Procter & Gamble Company, PureTek Corporation, QuestNutrition, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ventus Pharmaceuticals Private Limited, and Zoic Biotech Private Limited.

Market Segmentation & Coverage

This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Dietary Supplements and OTC Pharmaceuticals.
  • Based on Distribution, market is studied across Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and inclination of consumers towards self-medication products
      • 5.1.1.2. Government support to offer affordable and improved access to healthcare
      • 5.1.1.3. Growing adoption of private labels consumer healthcare products
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of counterfeit products that lack active pharmaceutical ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing approval rate of wellness and preventive medicines
      • 5.1.3.2. Rapid growth of online pharmacies and improved availability through online platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with abuse and misuse of consumer healthcare products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Consumer Healthcare Market, by Product

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. OTC Pharmaceuticals

7. Consumer Healthcare Market, by Distribution

  • 7.1. Introduction
  • 7.2. Departmental Stores
  • 7.3. Independent Retailers
  • 7.4. Pharmacies or Drugstores
  • 7.5. Specialist Retailers
  • 7.6. Supermarkets or Hypermarkets

8. Americas Consumer Healthcare Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Consumer Healthcare Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Consumer Healthcare Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia
    • 11.3.2. Nutrilitius expands portfolio with launch of new range of nutraceuticals, Unleashing the Power of Food Science & Technology
    • 11.3.3. LBB Specialties and DSM announce partnership for North America Dietary Supplements Distribution
    • 11.3.4. Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
    • 11.3.5. health supplements: Tata Consumer enters health supplements segment, launches plant protein powder
    • 11.3.6. Cipla Health to buy nutritional supplement brand Endura Mass
    • 11.3.7. Orkla Health acquires Healthspan
    • 11.3.8. Amway India launches nutrition supplements in gummies and jelly strips
    • 11.3.9. Wellbeing Nutrition raises $2.2 million led by Fireside Ventures
    • 11.3.10. Bayer launches Consumer Health division in India
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories Inc.
  • 2. Alembic Pharmaceuticals Ltd.
  • 3. Alkem Laboratories Limited
  • 4. AMCO Proteins
  • 5. American Health Inc.
  • 6. Amway Corporation by Alticor corporation
  • 7. Axtria Inc.
  • 8. BASF SE
  • 9. Bayer AG
  • 10. Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
  • 11. Boehringer Ingelheim International GmbH
  • 12. Cipla, Inc.
  • 13. Dr. Reddy's Laboratories
  • 14. Eli Lilly and Company
  • 15. Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
  • 16. Gemini Pharmaceuticals Inc.
  • 17. Glanbia PLC
  • 18. GlaxoSmithKline PLC
  • 19. Glenmark Pharmaceuticals Ltd.
  • 20. Henin Lukinz Pvt. Ltd.
  • 21. Herbalife Ltd.
  • 22. Hetero Drugs Ltd.
  • 23. Himalaya Wellness Company
  • 24. Iovate Health Sciences International Inc.
  • 25. Ipsen S.A.
  • 26. Johnson & Johnson Services, Inc.
  • 27. Koninklijke DSM N.V.
  • 28. Lonza Group Ltd.
  • 29. Lupin Limited
  • 30. Mankind Pharma
  • 31. MusclePharm Corporation
  • 32. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
  • 33. Nature's Bounty, Inc. by Nestle S.A.
  • 34. Novartis AG
  • 35. Omega Protein Corporation
  • 36. Pfizer Inc.
  • 37. Piramal Group
  • 38. Procter & Gamble Company
  • 39. PureTek Corporation
  • 40. QuestNutrition
  • 41. Reckitt Benckiser Group PLC
  • 42. Sanofi S.A.
  • 43. Sun Pharmaceutical Industries Limited
  • 44. Takeda Pharmaceutical Company Limited
  • 45. Teva Pharmaceutical Industries Ltd.
  • 46. Ventus Pharmaceuticals Private Limited
  • 47. Zoic Biotech Private Limited

LIST OF FIGURES

  • FIGURE 1. CONSUMER HEALTHCARE MARKET RESEARCH PROCESS
  • FIGURE 2. CONSUMER HEALTHCARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONSUMER HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONSUMER HEALTHCARE MARKET DYNAMICS
  • TABLE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY OTC PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DEPARTMENTAL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INDEPENDENT RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PHARMACIES OR DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SPECIALIST RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SUPERMARKETS OR HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023